We evaluated the incidence of Streptococcus pseudopneumoniae in clinical isolates by phenotypic methods and DNA-DNA hybridization. The pathogenic role of this organism was investigated with the mouse peritonitis/ sepsis model. Our results show a low incidence (1/120 pneumococcal isolates) and a potential pathogenic effect for S. pseudopneumoniae.
ambient air and in a 5% CO 2 atmosphere. Solubility in bile salt (sodium deoxycholate [Merck] ) was determined in tubes (4) . Capsules were detected by observing a halo around pneumococci with India ink at a ϫ100 to ϫ400 magnification. Capsular agglutination tests were performed by the Pastorex test (BioRad) according to the instructions of the manufacturer.
DNA-DNA hybridization was performed as described previously (8) . Hybridization between labeled DNA and the fragmented DNA preparation was carried out at 60°C for 16 h in 0.42 M NaCl by the nuclease-trichloroacetic acid method (3) . The values of DNA-DNA relatedness given are the means of the results of three independent experiments. Detection of ply in the extracted DNA was performed by PCR with primers specific for a 170-bp region, as described previously (1, 9) . The PCR products were analyzed by electrophoresis on 2% agarose gels, with visualization of the amplicon with ethidium bromide.
Immunocompetent 6-week-old Swiss mice were infected by intraperitoneal injection (0.5 ml) of an exponential-phase culture in brain heart infusion broth (Bio-Rad) (10 8 CFU per mouse) (2) and observed for a 7-day period. Controls received identical injections of broth. The experiments were performed in triplicate for each isolate and were repeated twice. Dead and sacrificed animals were examined; bacterial cultures of peritoneal fluid and spleen sections were performed on sheep blood agar, and spleen section imprints were Gram stained.
All 120 isolates were OPT susceptible in ambient atmosphere. Six strains (5%) were OPT resistant (zone size, 6 mm) when incubated in CO 2 . Among the six OPT-resistant isolates, three were capsular agglutination test negative, and two showed no capsule with India ink. All isolates were soluble in bile salt, except one (IBS-370), which was identified as S. pseudopneumoniae (OPT resistant in CO 2 , insoluble in bile salt, capsular agglutination negative, nonencapsulated).
DNA-DNA hybridization assays performed between strain IBS-370 and the type strains S. pneumoniae CCUG 28588 and S. pseudopneumoniae CCUG 49455 yielded values of 47% and 90%, respectively (Table 1) . DNA-DNA similarities of the other five OPT-resistant isolates were low (Ͻ50%) for S. pseudopneumoniae and varied for S. pneumoniae, being high (82%) for one S. pneumoniae isolate and low for the other (two unidentified isolates will need further study, and two isolates were identified phenotypically as S. constellatus and S. parasanguis). Both type strains as well as IBS-370 tested positive for ply ( T (lethal effect in 24 h) might be assigned to the capsule, which protects pneumococci from engulfment and digestion by macrophages and polymorphonuclear leukocytes during the host early immune response. Among the virulence factors required for invasive disease in S. pneumoniae, the lethal effect stems from the production of pneumolysin, the most broadly potent virulence factor (2, 6). The ply gene was shown to also be present in phylogenetically related species by horizontal transfer of genes, suggesting a pathogenic role (1, 5) . All S. pseudopneumoniae strains harbored the ply gene. S. pseudopneumoniae IBS-370, as well as all additional clinical strains, was clearly pathogenic, while S. pseudopneumoniae CCUG 49455
T showed no virulence, suggesting a lack of pneumolysin production or a lack of virulence cofactors which remain to be determined.
In our results, OPT-resistant streptococci in a CO 2 atmosphere included pathogens such as S. pseudopneumoniae and S. pneumoniae. OPT resistance in S. pneumoniae is uncommon but leads to problems in identification (1, 7) . Thus, for correct diagnosis and treatment of lower respiratory tract infections, OPT susceptibility testing should be performed in the ambient atmosphere rather than in CO 2 to avoid exclusion of OPTresistant S. pneumoniae and underestimation of pathogenic S. pseudopneumoniae. In addition, phenotypic identification can be completed by OPT susceptibility testing in CO 2 and bile salt solubility testing. Genotypic identification by DNA-DNA hybridization can be performed if necessary.
In conclusion, our results highlight a low incidence and potential pathogenic role of S. pseudopneumoniae. Furthermore, they underscore the complexity of oral streptococci regarding the relationship between their identification and the virulence factors produced. This may lead to laboratories taking account of oral streptococci isolated from specimens of patients suffering from severe lower respiratory tract infections. 
